**Core Concept**
The potassium repolarizing current is a crucial component of the cardiac action potential, particularly during the repolarization phase. Drugs that prolong the action potential duration by reducing this current can lead to arrhythmias and other cardiac complications.

**Why the Correct Answer is Right**
Drugs that consistently reduce the potassium repolarizing current include Class III antiarrhythmic agents, such as amiodarone, sotalol, and ibutilide. These drugs block the rapid component of the delayed rectifier potassium current (IKr), which is the primary potassium current responsible for repolarization. By blocking this current, these drugs prolong the action potential duration, increasing the risk of arrhythmias. Additionally, beta-blockers, like propranolol, can also reduce the potassium repolarizing current by reducing the sympathetic tone on the heart, thereby decreasing the rate of repolarization.

**Why Each Wrong Option is Incorrect**
* **Option A:** **Quinidine** is actually a Class IA antiarrhythmic agent, which primarily prolongs the action potential duration by blocking the sodium channels (INa) rather than the potassium repolarizing current.
* **Option B:** **Lidocaine** is a Class IB antiarrhythmic agent that primarily blocks the sodium channels (INa) and has little effect on the potassium repolarizing current.
* **Option D:** **Verapamil** is a calcium channel blocker that primarily affects the L-type calcium channels (ICaL) and has minimal effect on the potassium repolarizing current.

**Clinical Pearl / High-Yield Fact**
When managing patients with arrhythmias, it's essential to understand the mechanism of action of antiarrhythmic drugs and their potential effects on cardiac ion channels.

**Correct Answer: A. Quinidine**